Authors


Heather Wolf, PharmD Candidate

Latest:

Preparing for Your First IPPE

With summer quickly approaching, first-year pharmacy students will soon take their next steps to becoming pharmacists by beginning their first Introductory Pharmacy Practice Experience.


Christopher M. Blanchette, PhD, MBA

Latest:

Burden of Autosomal Dominant Polycystic Kidney Disease: Systematic Literature Review

The authors present a review of the literature for autosomal dominant polycystic kidney disease to characterize its impact on patients and healthcare systems.




Joseph L. Fink III

Latest:

Is a Discharged Pharmacist Eligible for Unemployment Benefits?

The court rules that the employee did not engage in willful misconduct, affirming the compensation board's decision.


François Laliberté, MA

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.


Logan Ryan

Latest:

Study Shows More Than 50% of Americans Have at Least 1 Chronic Health Condition, Mental Disorder, or Substance Use Issue

The election has brought discussion about the complexity of the US health care system to the forefront. A new study from Psychology, Health & Medicine reveals just how intricate the medical needs of Americans really are.


Joseph Menzin, PhD

Latest:

Annual Stroke Costs to Health Plans Among Atrial Fibrillation Patients

An incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.



Andrea Wagner, PharmD

Latest:

New Jersey Pharmacists' Perceptions of the New Jersey Prescription Monitoring Program

With prescription opioid overdoses leading to more deaths in the United States each year than cocaine and heroin combined, prescription drug abuse, misuse, and diversion have become growing concerns.


Amy Jang, PharmD Candidate

Latest:

Emergency Medications for Inpatient Treatment of COVID-19 Patients

The emergency use of drugs to shorten hospitalization and prolong time for COVID-19 vaccine research and development will serve as a critical temporary buffer for an efficient vaccine to combat SARS-CoV-2.


Jennifer Costello, PharmD, BCPS, BC-ADM

Latest:

Overcoming Patient Barriers in Glycemic Control: Clinical Advances in Combination GLP-1 and Insulin Therapy

This Continuing Education activity is supported by an educational grant from sanofi-aventis U.S.


Sara Karlovich, Assistant Editor

Latest:

ASHP Issues COVID-19 Vaccine Principles

The American Society of Health-System Pharmacists has issued a list of best practices to ensure an equitable distribution of the vaccine.


Tamara Bavendam, MD

Latest:

Work Productivity Associated With Treated Versus Never-Treated Overactive Bladder Symptoms

Overactive bladder symptoms can impair work productivity, especially among untreated adults, with work productivity impairment costs nearly twice as high for never-treated versus treated subjects.



Kimberly Firtz, PharmD, MSPBA, CSP

Latest:

Social Media Tribes: A Challenging Opportunity in Specialty Pharmacy

How the re-emergence of social media tribes has shifted patient expectations of specialty pharmacy communication


Sandro Rossetti, MD

Latest:

Burden of Autosomal Dominant Polycystic Kidney Disease: Systematic Literature Review

The authors present a review of the literature for autosomal dominant polycystic kidney disease to characterize its impact on patients and healthcare systems.


Robert Lee Page II, PharmD, FAHA, FCCP, BCPS, CGP

Latest:

Continuity of Care: Chronic Kidney Disease Across the Continuum

Caused by long-term, uncontrolled comorbidities, the incidence of chronic kidney disease is rising in the United States due to an aging population and an increase in diabetes cases.



Enteral Nutrition

Latest:

Infusion Pharmacist Expertise Vital in Helping Manage IG Shortages, Ensuring Right Drug Gets to the Right Patient at the Right Dose

Perceived as the new “wonder drug,” immunoglobulin (IG) is a go-to therapy for healthcare providers seeking to bolster their patients’ immune systems; however, as demand grows, particularly for oncology and off-label indications, the supply can’t keep pace.


Beth Cady, PharmD, BCPS

Latest:

The Down and Dirty on Sexually Transmitted Diseases

Sexually transmitted diseases (STDs) can be silent destructors. Patients may be unknowingly spreading infections or afraid to discuss them due to their sensitive nature.


Courtney Pagels, PharmD, BCIDP

Latest:

Optimize Clostridiodides difficile Tests and Diagnosis

The easiest way to avoid misdiagnosis, inappropriate treatment, and potential loss of reimbursement is to prevent unsuitable testing.


Surgery Center

Latest:

Pharmacist Feature Friday: Providing Hope for Patients with Neurological Diseases

It’s our job to spend as much time as it takes to help patients feel comfortable with the medications they are taking.


Lisa Neuman

Latest:

Findings from inTandem1 and inTandem2 Featured at ADA Scientific Sessions

Sotagliflozin effective in treating patients with type 1 diabetes.


Fuller Currie, PharmD candidate

Latest:

Opinion: Coronavirus Impact on Pharmacy Students in APPE Rotations

Three student pharmacists share their experiences adapting to APPE rotations during the COVID-19 pandemic,


Tetine Sentell, PhD

Latest:

Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs

Total cost of care for patients whose glycated hemoglobin levels were


Kenneth S. O'Rourke, MD

Latest:

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis

Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.


Amanda Daniels, PharmD

Latest:

Sodium-Glucose Co-Transporter-2 Inhibitors: An Update on the Evidence for Treatment of Type 2 Diabetes

Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.



Heather Steelman Coleman, PharmD

Latest:

Case Report: Congestive Heart Failure

The patient's heart failure needs to be classified to determine the appropriate treatment strategy.